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Abstract 
Previous empirical research demonstrated that major depressive disorder (MDD) had a 
profound impact on adults. What remained unaddressed in the research was the ability of 
those with MDD to form positive responses during challenging life events. The purpose 
of this exploratory quantitative study was to examine the cognitive ability of MDD 
patients to form positive responses on a standardized psychological assessment. This 
study, guided by Beck’s cognitive theory of depression, was designed to determine 
whether depressed individuals were prone to negativity and had decreased ability to form 
positive responses to challenging situations. A 2x2 ANOVA was used to analyze 116 
participants who voluntarily completed the Changes in Outlook Questionnaire (CiOQ). 
Results indicated that the group diagnosed with MDD scored significantly lower than a 
control group on the positive response scale of the CiOQ and that men diagnosed with 
MDD scored significantly lower than women diagnosed with MDD on the positive 
response scale of the CiOQ. This research has positive social change implications in that 
practitioners may use the findings in developing more effective treatments to help those 
with MDD to learn to form positive responses in the midst of challenging life events. 
Practitioners may also develop their ability to recognize when men with MDD are 
depressed by using the CiOQ to obtain written responses from individuals who do not 
verbalize depression. This research may also be useful for future research and application 
within the field.  
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Chapter 1: Introduction to the Study 
Introduction 
Major depressive disorder (MDD) was traditionally treated with pharmacology; 
approaches to MDD have been updated in response to developments in theoretical and 
psychological frameworks of treatment (National Institute of Mental Health [NIMH], 
2011). The professional literature has shown that those diagnosed with MDD can be 
resistant to traditional treatment methods and are increasingly prone to relapse (NIMH, 
2011). For example, in one year, a total of 6.7% of the population in the United States 
was diagnosed with MDD, with 30.4% of those cases labeled as severe (NIMH, 2011). 
Hart, Craighead, and Craighead (2001) reported that 50% of those who recovered from 
MDD were at significant risk for recurrence of the disorder within 3 years of the initial 
diagnosis. Hart et al. further stated that “the cascading effect of recurrent depression 
makes clear the need for effective methods to prevent relapse and recurrence of MDD” 
(p. 633). 
Research has also shown that female participants tended to be more prone to 
MDD in the midst of stressful life events (SLEs) when compared to male participants 
(Harkness et al., 2010; Stroud, Davila, Hammen, & Vrshek-Schallhorn, 2011). This study 
was intended to show that those coping with MDD may require more specific individual 
and group psychological interventions to circumvent their cognitive impairments, which 
could interfere with their ability to form positive responses, in order to maintain optimum 
mental health.  
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Background 
The NIMH (2011) reported that MDD is one of the most debilitating disorders 
nationwide. The American Psychiatric Association (APA; 2000) defined MDD as the 
most severe of the three types of depressive disorders, with the other two depressive 
disorders being dysthymic disorder and depressive disorder not otherwise specified. The 
APA reported that 15% of persons diagnosed with MDD would eventually complete a 
suicide attempt, and individuals over 55 years of age  who committed suicide were 4 
times higher when compared to younger individuals (APA, 2000). The NIMH (2011) 
reported that persons between the ages of 30 to 44 were 120% more likely to be 
diagnosed with MDD, with the effects of MDD being as debilitating as those of major 
medical illnesses. Rothermund and Brandstater (2003) administered an 8-year 
longitudinal study that examined depression in an elderly population and found that 
complex symptoms of MDD appeared to increase with age. Their study showed a 
correlation between late onset of severe depression with perceptions of moving toward 
death rather than aging, which included loss of control, decreased openness to life 
experiences, and loss of coping resources (Rothermund & Brandstater, 2003). 
The NIMH (2011) reported that 6.7% of individuals who lived in the United 
States had experienced depression for a 12-month period and that individuals aged 18 
through 29 were 70% more likely  than those of other age groups to experience 
depression. The report also showed that women were 70% more likely than men to be 
diagnosed with depressive disorder (NIMH, 2011). Harkness et al (2010) investigated 
stressful life events in men and women to determine if these events were correlated with 
an increased predisposition for depression in women. Results from the study indicated 
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that women were significantly more likely to have an occurrence of MDD between the 
ages of 18 and 29 (Harkness et al., 2010). Results also indicated that women were more 
likely to report the occurrence of a severe life event (SLE) prior to the onset of MDD 
(Harkness et al., 2010). Additional research conducted by Stroud et al. (2011) focused on 
severe life events (SLEs) and lower severity events (LLEs). Stroud et al. found 
correlations with the onset of depression in 155 adult female participants identified as 
culturally varied, middle class, and age 19 to 29. The study noted whether the 
participants’ life events were interpersonal, involved relationship loss, or involved death 
(Stroud et al., 2011). Results from the study indicated a decrease in the tendency for 
SLEs with recurrence of major depressive episodes; however, relationship loss SLEs and 
LLEs significantly correlated with first onset and prior onset of depression (Stroud et al., 
2011).  
The DSM-IV-TR Criteria for Diagnosis of MDD 
Depressive disorders were one of the three types of mood disorders identified in 
the DSM-IV-TR (APA, 2000). The symptoms differed in duration and severity and were 
defined in three categories: MDD, dysthymic disorder, and depressive disorder not 
otherwise specified (APA, 2000). MDD was the most severe form of depression and was 
diagnosed when patients demonstrated at least five of the following: (a) daily depression 
or sadness, (b) the inability to experience happiness or joy in activities, (c) a total of at 
least 5% weight gain or weight loss, (d) insomnia or hypersomnia, (e) psychomotor 
agitation or slow psychomotor activity, (f) excessive fatigue and lack of energy on a daily 
basis, (g) low self-esteem and self-worth with thoughts to the extent of being delusional 
in nature, (h) consistent indecisiveness, and (i) thoughts of death, dying, or thoughts of 
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committing suicide with or without plans of action (APA, 2000, p. 356). Additional 
criteria for MDD included (a) marked impairment in social, academic or occupational 
areas of life; (b) symptoms not due to a mixed episode of mood disorder, substance 
abuse, substance dependence, or a medical condition; (c) symptoms not due to losing a 
loved one unless they last for at least 2 months with marked focus on preoccupation with 
death, dying, or suicide; decreased sense of self-worth; and marked change in 
psychomotor activity (APA, 2000, p. 356). Some individuals diagnosed with MDD also 
evidenced psychotic features due to the severity of the depression (APA, 2000, p. 370). 
When this occured, the practitioner needed to specify “Major Depression With Psychotic 
Features” (APA, 2000, p. 370).  Thus, the cognitive components of MDD can be 
overwhelming in their perplexity and severity, and these aspects of MDD require 
therapeutic intervention. 
Basic Symptoms of Major Depressive Disorder 
According to the research conducted by Stroud et al. (2011), patients with MDD 
experience feelings of hopelessness, helplessness, and avolition, as well as thoughts of 
death, dying, or suicide. The individual who is diagnosed with MDD believes that he or 
she will not be able to recover or feel better because this is part of the symptomology of 
depression (Corey, 2009). The person with MDD may be prone to feeling that many 
aspects of life will only become worse, and the person may continue to experience 
negative thoughts and ruminations that create a downward spiral in his or her moods, 
thoughts, feelings, overall perceptions, and responses to life events (Corey, 2009). The 
negativity in the thoughts of those with MDD is not deliberate; rather, it indicates a 
clinical level of impairment.  
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Research conducted by deRoon-Cassini, Mancini, Rusch, and Bonnano (2010) 
showed that patients who were diagnosed with MDD experienced a combination of 
emotional, psychological, and physical symptoms and life stressors. Gonzalez, Reynolds, 
and Skewes (2011) reported that individuals who were diagnosed with substance abuse, 
chronic pain, physical illness, and anxiety disorders were prone to being diagnosed with 
MDD (de-Roon-Cassini et al., 2010; NIMH, 2011). Tate et al. (2008) also reported that 
there was a tendency for those with comorbid depression and substance abuse disorders 
to have experienced complications without receiving adequate treatment and to have 
experienced increased  severity of depressive symptoms and potentially harmful side 
effects from difficulties with medication management. 
Statement of the Problem 
According to the NIMH (2011), the efforts of mental health professionals who 
treat individuals with MDD have yielded limited success with regard to reducing 
symptoms, recurrence, or relapse. Current research has shown that individuals diagnosed 
with MDD continued to follow treatment plans that were not efficacious for severe or 
long-term depression (NIMH, 2011). As a result, those diagnosed with MDD might have 
been set up more for failure than for recovery when they attempted to perform traditional 
therapeutic tasks that they were unable to perform due to being incapacitated (Doumas, 
Smolders, Brunfault, Bouckaert, & Krampe, 2011). 
Some of the most debilitating symptoms for individuals diagnosed with MDD 
include negative changes in thought content and thought processes (Beck, 1976; Doumas 
et al., 2011; Segal, Williams, & Teasdale, 2003). According to Craighead, Sheets, 
Craighead, and Madsen (2011), the term negative changes in cognition refers to 
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decreased thought content, lack of ability to focus and concentrate, difficulty with 
comprehension, and lack of timely response to information. In the most severe cases, 
patients with MDD experience psychotic thought processes that include auditory 
hallucinations, paranoia, delusional thought content, incoherence, aphasia, and psychotic 
regression to the point where the individual is unable to adapt or cope with reality 
(NIMH, 2011). In the process of forming a diagnostic plan, mental health practitioners 
have been required to specify if patients with MDD evidence psychotic features (APA, 
2000). The severity of cognitive symptoms is a distinguishing factor in diagnosing MDD, 
as it indicates the severity of impairment (Riso et al., 2003).  
In this study, I expected to show that individuals who were diagnosed with MDD 
evidenced significantly lower scores on the positive response scale of the Changes in 
Outlook Questionnaire (CiOQ) than those without any clinical mental disorder, which 
would indicate that there was impairment in their cognitive ability. In addition, I 
investigated whether female participants diagnosed with MDD evidenced lower scores on 
the positive response scales of the CiOQ when compared to male participants diagnosed 
with MDD, as previous studies indicated that females were more prone to being 
diagnosed with MDD than men during change or stressful life events (Harkness et al., 
2010). Due to a lack of demographic variation in the geographic location where the 
research was conducted, the variables were limited to gender (Leu, Wang, & Koo, 2011). 
Nature of the Study 
This exploratory, quantitative study was guided by research questions and 
hypotheses, which are presented in the next section. The research question was derived 
from a thorough review of the existing professional literature. 
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Research Questions and Hypotheses 
Research Question 1: Will there be a difference in positive responses when those 
diagnosed with MDD are compared to participants without a diagnosis of MDD? 
Ho1 :Participants diagnosed with MDD will not report significantly lower scores 
for positive responses as measured by the CiOQ when compared to participants without a 
diagnosis of MDD. 
Ha1 :Participants diagnosed with MDD will report significantly lower scores for 
positive responses as measured by the CiOQ when compared to participants without a 
diagnosis of MDD. 
Research Question 2: Will there be a gender difference in the number of positive 
responses in those who are diagnosed with MDD? 
Ho2 :Female participants diagnosed with MDD will not report significantly lower 
scores for positive responses as measured by the CiOQ when compared with male 
participants diagnosed with MDD. 
Ha2 :Female participants diagnosed with MDD will report significantly lower 
scores for positive responses as measured by the CiOQ when compared with male 
participants diagnosed with MDD. 
Purpose of the Study 
The purpose of this quantitative exploratory study was to determine if individuals 
who were diagnosed with MDD evidenced significantly lower scores on the positive 
response scale of the CiOQ when compared to others who were not diagnosed with any 
clinical mental disorder. 
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The results provide empirical data to assist mental health practitioners in 
identifying the level of cognitive impairment and emotional limitations experienced by 
those with MDD during the initial phase of an evaluation. This study may prompt mental 
health practitioners to work collaboratively to add treatment goals that address the needs 
of those diagnosed with MDD more specifically. Currently, individuals who have been 
diagnosed with MDD in intensive outpatient programs receive treatment plans similar to 
those given to patients diagnosed with other disorders, despite the severity of their 
cognitive impairment (NIMH, 2011). For example, patients with MDD may be referred 
to an outpatient program that provides individual and group therapy for patients with 
anxiety disorders or other mental health disorders (Leahy, Holland, & McGinn, 2012). If 
the needs of those with MDD exceed the needs of others with different disorders, as 
indicated by the American Psychiatric Association (2000), then it is possible that these 
needs are not being met. This study has positive social change implications in promoting 
more positive outcomes and less recurrence of symptoms in this misunderstood 
population.  
Theoretical Framework of Cognitive Behavior Therapy and Cognitive Therapy 
Cognitive behavior therapy (CBT) is an area of psychotherapy that uses a 
combination of cognitive and behavioral principles for a short-term treatment approach 
with patients (Corey, 2009). One of the theories noted within the framework of CBT is 
Beck’s (1963) cognitive therapy (CT; Corey, 2009). Beck (1963) developed CT to work 
with patients diagnosed with clinical depression, and it is still being used for the 
treatment of depression (Dozois et al., 2009). Beck (1963) observed that individuals with 
depression evidenced a negative bias when viewing life events that predisposed them to 
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cognitive distortions and further increased the likelihood of even more negativity (Beck, 
1963). The intention of CT was to promote insight and self-awareness and to assist the 
patient in changing his or her negative thinking patterns and beliefs (Dozois et al., 2009). 
Some cognitive therapists believe that if depressed individuals can change their 
perceptions and irrational beliefs about life situations, they can form more proactive 
behaviors and prevent the recurrence of depressive thinking (Beck et al., 1963; Dozois et 
al., 2009).  
Definitions of Terms 
The following terms are defined as they are used in this study:  
Augmentation: Antipsychotic medication combined with antidepressant 
medication prescribed for individuals diagnosed with MDD who have prolonged 
resistance to antidepressant medication alone (Klein et al., 2011).  
Challenging life event: Any event that challenges the individual to adapt to a 
situation.  
Changes in Outlook Questionnaire (CiOQ): A standardized psychological 
screening assessment that measures for positive and negative response rates in the midst 
of challenging or traumatic life events (Joseph, Williams, & Yule, 2003).  
Comorbidity: Described when an individual meets the criteria for two or more 
mental health disorders at the same time (APA, 2000).  
Depressive disorders: A group of three disorders identified in the DSM-IV-TR by 
the criteria for individuals experiencing subclinical to clinical levels of depression, 
including major depressive disorder, dysthymic disorder, and depressive disorder not 
otherwise specified (APA, 2000).  
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Major depressive disorder (MDD): MDD is the most severe of the three forms of 
depressive disorders (APA, 2000).  
Monoamine oxidase inhibitors (MAOIs): Antidepressant medications used for the 
treatment of MDD and other depressive disorders (Cipriani, Geddes, Furukawa, & 
Barbui, 2007). 
Pharmacotherapy: History and description of medications used for the treatment 
of depressive disorders (Beck et al., 1979). 
Positive response rate: The total of 11 positive items on the CiOQ, which are self-
reported (Joseph, Williams, & Yule, 2003).  
Poverty of thought content: When an individual expresses an inability to think or 
express the subject matter or the content of his or her thoughts (APA, 2000).  
Selective serotonin reuptake inhibitors (SSRIs): A class of medications used for 
the treatment of MDD and depressive disorders (Cipriani et al., 2007). 
Tricyclic antidepressants (TCAs): Medications used for the treatment of 
depressive disorders (Cipriani et al., 2007). 
Assumptions, Limitations, and Scope 
Assumptions 
The following assumptions were made in this study: 
1. It was assumed that all participants placed into the MDD group met the 
criteria for MDD as indicated by the DSM-IV-TR (APA, 2000). 
2. It was assumed that all participants were able to read, write, and communicate 
in English as their primary language or be culturally literate with English as a 
second language. 
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3. It was assumed that participants answered all of the questions in the CiOQ to 
the best of their ability.  
4. It was assumed that all participants willingly agreed to participate in the study 
by having provided their informed consent. 
5. It was assumed that the purposive sampling of convenience of participants 
was representative of the target population of referrals to the counseling center 
being used for this study, but generalizing the results of the study beyond the 
sample should be done with caution. 
6. It is assumed that the findings would have a wider applicability among 
patients with MDD with demographics similar to those who participated at the 
counseling center for this study.  
Limitations 
The following limitations were recognized in this study: 
1. The data obtained in this study were limited by participants’ cultural, ethnic, 
and socioeconomic status; therefore, generalizing the results to other cultures, 
cities, and states should be done with caution. 
2. The participants were individuals who had access to transportation to the 
study site. The study was therefore limited in the ability to represent 
individuals who were unable to secure transportation to participate in the 
study. Therefore, the results should be used with caution. 
3. This study included individuals between the ages of 18 and 49; therefore, 
generalizing the results to a population of individuals under the age of 18 or 
over the age of 49 should be done with caution. Participants under the age of 
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18 were not considered to be adults, and participants over the age of 49 were 
considered more susceptible to health or hormonal changes that could have 
increased the chances of confounding variability in the groups of participants. 
4. Interviewers might not have asked or participants might not have accurately 
disclosed how participants identified their race/ethnicity, so the number of 
participants from a particular group might not have been accurately recorded.  
5. Thoughts, attitudes, beliefs, and perceptions of the participants and the 
evaluators were limited to those measured by the diagnostic instruments used. 
Data might be limited by the biases of the interviewers, who might or might 
not have been culturally sensitive. 
6. Data were based on participants’ self-reports on the CiOQ. The limits of self-
report included the negative stigma that could come with reporting 
unfavorable patterns or behaviors, which may have caused some participants 
to respond in ways they felt made them more socially acceptable (Beck, Steer, 
& Brown, 1996). This might have included complete or partial denial of 
behaviors and characteristics that were deemed undesirable by society.   
7. It was unclear what impact the sample size would have on this study due to 
the limited number of participants at one mental health location. Therefore, 
generalizing the findings should be done with caution.  
8. Definitions of terms were limited to those provided by the instruments used in 
the study. Therefore, generalizing terms to other uses should be done with 
caution. Any developmental disorders, learning disabilities, substance abuse, 
or mood disorders other than MDD were ruled out during the intake 
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assessment conducted by the attending psychiatrist on site, as they were 
considered to be potential cofounders. 
Scope 
The scope of this study included a literature review, two research questions, 
hypotheses, variables, and a theoretical framework. The goal for this study was based on 
a gap in the current professional literature in reference to whether individuals diagnosed 
with MDD are as capable of forming positive responses as individuals without a clinical 
mental disorder are. There was also a need to identify whether women diagnosed with 
MDD evidenced lower scores on positive response scales of the CiOQ when compared to 
men diagnosed with MDD, as previous studies indicated that women had a greater 
tendency to be diagnosed with MDD when they perceived and experienced challenging 
or stressful life events (Harkness et al., 2010). The variable of positive response rates on 
the CiOQ was chosen for this study because those with MDD might not have been able to 
form positive responses due to the severity of their cognitive impairment (APA, 2000; 
Beck, 1976; Craighead et al., 2011; Doumas et al., 2011; Segal, Williams, & Teasdale, 
2003). A thorough review of the literature showed that there was no previous empirical 
research that used a standardized psychological assessment to measure positive response 
rates in those diagnosed with MDD. The goal of this study was to highlight a potential 
cognitive difference in persons with MDD that makes traditional therapeutic treatments 
ineffective for this target population and instead contributes to relapse and recurrence. 
Identifying persons with MDD as a potentially misunderstood population might help in 
the effort to adapt more specific treatment methods to this target population and to reduce 
episodes of recurrence and relapse.  
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Significance of the Study 
The significance of this study resides in its potential to draw attention to the 
treatment of depression and to prompt practitioners to recognize the need for more 
specific interventions for the treatment of those suffering with MDD, which has been 
noted as one of the most severely troubling of all of the psychiatric disorders (Leahy, 
Holland, & McGinn, 2012). It has been reported that MDD is the leading cause of 
disability in the United States among individuals between the ages of 15 and 44 years 
(Leahy et al., 2012). It is of utmost importance for mental health practitioners to realize 
that up to 61% of those with MDD have never pursued treatment for the disorder (Leahy 
et al., 2012). Those affected by MDD may be concurrently impaired in their ability to 
work and often demonstrate low efficiency, lack of focus, and difficulty with 
organization at the workplace (Leahy et al., 2012). In addition, MDD has been correlated 
with a 35% decrease in lifetime income (Leahy et al., 2012). Therefore, MDD not only 
affects the individual on an emotional level, but also has a downward spiraling effect that 
touches many aspects of the individual’s life experiences, which further complicate his or 
her life and only reinforce the tendency for an increase in depressive symptoms (Leahy et 
al., 2012).  
Social Change Implications 
This study has implications for social change in that it shows that the level of 
cognitive impairment in those with MDD results in them being significantly less capable 
of forming positive responses and therefore unable to accept the benefits of traditional 
therapeutic treatments. Psychologists may be challenged by this research to develop more 
efficacious psychotherapeutic interventions for patients diagnosed with MDD, as the 
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current research literature indicates that individuals with MDD are among the most 
disabled in the United States (Leahy, Holland, & McGinn, 2012). A lack of cognitive 
ability to form positive responses in the midst of challenging life events may make those 
with MDD most susceptible to resistance to treatment or to relapse. Perhaps future 
psychological interventions could be developed to help patients with MDD learn how to 
form positive responses in the midst of challenging life events in order to increase their 
chances for recovery.  
This research has the potential to support positive social change not only on the 
individual level, but also on the group level, as families of those with MDD may also be 
involved in their treatment. In addition, the results of this study could have impacts on 
group, institutional, and organizational systems. Learning how to form positive responses 
in the midst of challenging life events could be taught in workplaces, groups, volunteer 
facilities, communities, and organizations that strive to bring positive transformation to 
society as whole.  
This study could be regarded as applicable not only to those diagnosed with 
MDD, but also to those who strive for overall improvement in coping, development, and 
positive transformation on the individual, group, organizational, and societal levels. The 
results of this study could prompt social change within the field of psychology. Mental 
health practitioners may gain further insight into specific cognitive limitations that 
contribute to the relapse and recurrence rates of those diagnosed with MDD (NIMH, 
2011). Results from this study could prompt mental health practitioners to strive to 
develop new psychotherapeutic interventions that specifically focus on helping those with 
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MDD to develop the cognitive ability to form positive responses in the midst of 
challenging life events.  
Summary and Transition 
According to the current professional literature, the efforts maintained by 
psychiatrists and psychologists to offer effective treatment methods for MDD have 
yielded limited success (NIMH, 2011). Research has indicated that individuals diagnosed 
with MDD continue to be provided with treatment plans that are ineffective for severe or 
long-term depression (Riso et al., 2003). As a result, those diagnosed with MDD may be 
set up for failure more than for recovery when treating professionals encourage them to 
attempt to perform therapeutic tasks in a similar manner to those who do not suffer the 
same incapacitating symptoms. This treatment pattern does not reflect awareness that 
patients with MDD have a higher level of cognitive impairment, which creates a barrier 
to the performance of routine tasks. Without information on individual cognitive ability, 
ineffective treatment may reinforce a patient’s ideas of inability and incapacity, refueling 
depressive and negative symptoms and creating further feelings of failure (Riso et al., 
2003).  
There was a gap in the empirical data from previous studies that measured the 
cognitive level of impairment for those diagnosed with MDD, particularly in their ability 
to form positive responses on a standardized psychological assessment. Results of my 
study show that participants diagnosed with MDD had significantly lower positive 
response rates when compared with participants without any clinical mental disorder. 
This may mean that those diagnosed with MDD were not receiving appropriate 
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psychotherapeutic interventions given the severity of their condition and were thus an 
underserved population.  
The results of this study may prompt mental health practitioners to work 
specifically on helping these patients form the necessary positive responses to life events 
and stressors that would promote optimal and possibly long-term mental health. 
Improvement in these individuals’ ability to form positive responses might, in turn, create 
an overall increase in their ability to interact with their caretakers, family, friends, and 
colleagues, and might help them to accept that they are being supported. Therefore, my 
study has the potential to create positive social change at the individual, family, group, 
institutional, organizational, and global levels.  
This study integrated the theoretical framework of cognitive therapy (CT) for 
depression and the treatment of depression, as developed by Beck, Rush, Shaw, and 
Emery (1979). The literature review in Chapter 2 provides a thorough analysis of the 
theory of CT, which shows the reader how the negative thoughts of a person with 
depression deepen and expand into negative assumptions and conclusions about the self, 
life experiences, and the future (Beck et al., 1979). Chapter 2 also shows how the CT 
developed by Beck helps patients identify the negativity that pervades their thinking and 
confront those thoughts in order to replace negative assumptions and beliefs with more 
realistic and rational thoughts (Beck et al., 1979). This study incorporated Beck’s theory 
of cognitive therapy in collaboration with a standardized tool that measures the cognitive 
ability of those diagnosed with MDD to form positive responses in the midst of 
challenging life events.  
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Chapter 2 presents a thorough review of the literature regarding the criteria for 
MDD, the development of cognitive therapy (CT), the terms used in CT, the history of 
pharmacotherapy, and the research methods used in past studies. Evidence of insufficient 
recovery rates, the severity of recurrence despite psychotherapy and medication 
monitoring, and the severity of cognitive impairment is integrated to justify the need for 
the study.  
In Chapter 3, I discuss the research methodology for this study, including the 
research design, setting and sample, instrumentation, data collection and data analysis 
procedures, and measures taken to protect the participants’ rights. Chapter 3 addresses the 
study’s implications for positive social change and ethical considerations related to the 
use of the data.  
Chapter 4 presents the research findings of this experimental study. This chapter 
includes the methods that were used in the study, a description of the sample, the results 
for each research variable, an overview of the procedures used, and a summary of the 
results obtained. The results of the study are indicated in tabular and textual form.  
Chapter 5 provides a brief overview of the study, an interpretation of the results, 
implications for positive social change, and recommendations for action and further 
research.  
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Chapter 2: Literature Review 
 The purpose of this study was to determine whether individuals with MDD were 
capable of forming positive responses on the CiOQ or were incapable of doing so due to 
significant cognitive impairment that could have interfered with current available 
treatment methods. This chapter includes an overall review of the literature related to the 
study. It provides an overview of the current professional research on MDD and the 
limitations experienced by those diagnosed with the disorder. The chapter contains a 
synopsis of the key words used in the literature search and the database sources used to 
collect the current professional literature. Next, there is a review of the history and 
available treatments for MDD. This is followed by a review of the theoretical perspective 
taken in this study. A review of the literature with an emphasis on cognitive deficiencies 
in those diagnosed with MDD is included. Following is a review of the literature on 
MDD and a review of contemporary research trends and methods used in previous 
studies on the combination of CT and medication to treat MDD. Next is a review of 
research trends and methods used in previous studies on MDD, including the greater 
tendency of women to report stressful life events when diagnosed with MDD. Finally, a 
summary of the chapter is provided.  
Literature Search 
 The following databases were searched: (a) PsychINFO, (b) SocINDEX with full 
text, (c) PsycARTICLES, and (d) Academic Search Premier. The American Psychiatric 
Association’s Diagnostic and Statistical Manual of Mental Disorders, Text Revision 
(DSM-IV-TR) and the website for the National Institute of Mental Health were also used 
for this literature review. The following key search terms were used: major depressive 
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disorder, cognition, cognitive-therapy (CT), The Changes in Outlook Questionnaire 
(CiOQ), The Structured Clinical Interview for DSM Disorders (SCID-II), 
pharmacotherapy, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants 
(TCAs), selective serotonin reuptake inhibitors (SSRIs), and augmentation 
pharmacotherapy. The scope of the literature search was limited to articles and scholarly 
literature published in the last 10 years. An exception was made with reference to 
material related to the history and the theoretical foundation of cognitive therapy (CT) for 
depressive disorder. Several hundred articles were reviewed regarding depression, MDD, 
cognition in those diagnosed with MDD, pharmacotherapy for the treatment of 
depression, recurrence of MDD, and the resistance of MDD to psychotherapy and 
medical treatment. Articles not directly related to the topic of study were excluded. There 
was a need for additional research concerning what was missing in the treatment of those 
with MDD that impacted their ability to improve. 
Professional Standards 
 Mental health practitioners have made moderate progress in the development of 
treatment for mental health disorders, and researchers in the fields of psychiatry and 
neurology have contributed to the development of pharmacotherapy to treat numerous 
psychiatric ailments (Seo, MacPherson, & Young, 2010). Psychologists have developed 
new insights and theories of psychotherapy for patients in need of counseling (Corey, 
2009). According to Hersen, Turner, and Beidel (2007), mental health practitioners have 
observed that those diagnosed with MDD evidence a better chance of recovery with a 
decreased chance of recurrence if they receive early intervention through 
pharmacotherapy and psychotherapy. The purpose of this study was to determine whether 
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individuals with MDD evidenced significant cognitive impairment that interfered with 
available treatment methods and prevented their ability to recover from symptoms of 
MDD. 
Purpose of the DSM-IV-TR for Identifying Disorders 
The DSM-IV-TR (APA, 2000) is based on the medical model of mental illness 
and is the most widely used diagnostic tool for clinical mental illness, personality, and 
developmental disorders (Remley & Herlihy, 2010). According to Remley and Herlihy 
(2010), the main purpose of the DSM-IV-TR is to provide a systematic description of 
mental health disorders using universal language and criteria. The DSM-IV-TR assists 
the practitioner in forming optimal treatment plans, given the nature and severity of the 
pathology observed in each patient, including medical disorders that may need the 
attention of a physician (Remley & Herlihy, 2010). The DSM-IV-TR also provides an 
appendix that helps to ensure that cultural competence is maintained during the 
diagnostic process.  
 Some mental health practitioners who identify with the wellness model believe it 
is negative to focus on psychopathology (Remley & Herlihy, 2010). In practice, 
psychologists and psychiatrists form a multiaxial diagnosis for treatment purposes and 
consider medical disorders, comorbid disorders, and differential diagnoses to be 
important aspects of diagnoses used in patient treatment (Comer, 2007). Some 
individuals might be less likely to pursue treatment if the practitioner does not use the 
DSM-IV-TR, as a formal diagnosis is required for patient expenses to be covered with 
health insurance carriers (APA, 2000; Comer, 2007). According to Herlihy, Watson, and 
Patureau-Hatchett (2008), some mental health practitioners are troubled by the practice of 
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labeling patients with psychopathology for the sake of health insurance coverage and 
payments.  
 Research suggests that it is important for mental health practitioners to be mindful 
of the risks involved in applying labels to patients, as patients may be prone to identifying 
with diagnostic labels (APA, 2000). This is especially true for individuals who suffered 
with MDD because, by definition, they are prone to heightened feelings of hopelessness, 
helplessness, excessive rumination, and negativity (APA, 2000).  
 This study explores whether the symptoms of MDD create an inability for 
individuals to form positive responses in the midst of challenging and stressful life 
situations. Highlighting this possibility may uncover a need for practitioners to guide 
these patients to identify MDD as the disorder that affects them, rather than a disorder 
that defines them.  
The DSM-IV-TR Criteria for Diagnosis of Major Depressive Disorder 
Depressive disorders are one of the three types of mood disorders identified in the 
DSM-IV-TR (APA, 2000). The symptoms differ in duration and severity and are defined 
in three categories: MDD, dysthymic disorder, and depressive disorder not otherwise 
specified (APA, 2000). MDD is the most severe form of depression and is diagnosed 
when patients demonstrate at least five of the following: (a) daily depression or sadness, 
(b) the inability to experience happiness or joy in activities, (c) a total of at least 5% 
weight gain or weight loss, (d) insomnia or hypersomnia, (e) psychomotor agitation or 
slow psychomotor activity, (f) excessive fatigue and lack of energy on a daily basis, (g) 
low self-esteem and self-worth with thoughts to the extent of being delusional in nature, 
(h) consistent indecisiveness, and (i) thoughts of death, dying, or thoughts of committing 
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suicide with or without plans of action (APA, 2000, p. 356). Additional criteria for MDD 
include (a) marked impairment in social, academic, or occupational areas of life; (b) 
symptoms not due to a mixed episode of mood disorder, substance abuse, substance 
dependence, or a medical condition; (c) symptoms not due to losing a loved one, unless 
they last for at least 2 months with marked focus on preoccupation in thoughts toward 
death, dying, or suicide; decreased sense of self-worth; and marked change in 
psychomotor activity (APA, 2000, p. 356). Some individuals diagnosed with MDD also 
evidence psychotic features due to the severity of the depression (APA, 2000, p. 370). 
When this occurs, the practitioner has to specify “Major Depression With Psychotic 
Features” (APA, 2000, p. 370).  Thus, the cognitive components of MDD can be 
overwhelming in their perplexity and severity, and these aspects of MDD require 
therapeutic intervention.  
The History of Pharmacotherapy Treatment for MDD 
 A brief review of the development of pharmacotherapy for the treatment of 
depression was provided by Seo, MacPherson, and Young (2010). The development of 
pharmacotherapy for the treatment of depression was based on the notion that depression 
was primarily due to a neurochemical imbalance (Seo et al., 2010). Seo et al. noted that 
monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressant medications (TCAs) 
were the first principal types of medication to treat depression. Their study also showed 
that bothersome and potentially dangerous side effects occurred with MAOIs and TCAs 
and overwhelmed patients as much as the depression itself (Seo et al., 2010). Their 
research eventually revealed that selective serotonin reuptake inhibitors (SSRIs) were 
24 
 
effective for the treatment of depression and had far fewer side effects than the MAOIs 
and the TCAs (Seo et al., 2010).  
 In current practices it was noted that psychiatrists and physicians use SSRI 
medications as the first choice for the treatment of depressive disorders, but patients with 
long-term, severe depression continued to show resistance to treatment despite the overall 
benefits of the SSRIs (Delgado & Ehert, 2011). Many of the medications used for 
augmentation had more negative and potentially harmful side effects, which became 
problematic for patients with more severe forms of depression (Seo et al., 2010). 
However, Delgado and Ehert (2011) proposed that certain atypical antipsychotic 
medications were efficacious for treatment in collaboration with SSRIs and did not pose 
as high of a risk of negative and severe side effects in some patients. Research suggested 
that those who were diagnosed with MDD may have had imbalances in dopamine and 
serotonin, and antipsychotic medications, which included aripripazole and quetiapine 
balanced the feedback mechanisms of these neurotransmitters within the brain (Delgado 
& Ehert, 2011).  
Despite the ongoing development of pharmacotherapy within the medical and 
psychiatric arenas, the research showed there were still large numbers of individuals on a 
global level that were resistant to pharmaceutical treatments.  My study intended to show 
the possibility that those who suffered with MDD needed more individual or specific 
psychological interventions to learn how to circumvent their cognitive impairments, 
which contributed to their inability to form positive responses.  
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Combining Psychotherapy and Pharmacotherapy for MDD 
 Current research focused on the practice of combining psychotherapy and 
medication monitoring for the effective treatment of depression. Manber, Kraemer, 
Arnow, Trivedi, Rush, Thase, and Keller (2008) conducted studies over a three-month 
period, which utilized individuals diagnosed with MDD who were in acute remission in 
three treatment groups: antidepressant medication, psychotherapy, and a combination of 
antidepressant medication and psychotherapy. Observations were made to account for 
predictors of remission during acute phases of MDD (Manber et al., 2008). The 
participants in the study included adults, ages 18 to 75 years with a mean of 43.5 years. A 
total of 65.4% of the participants were female and all participants were evaluated and 
diagnosed according to criteria of the Structured Clinical Interview for DSM disorders 
(SCID) (First, Spitzer, Gibbon, & Williams, 1994). Participants were placed into one of 
three groups: (1) those who met criteria for Major Depressive Episode (MDE) for two 
years without prior diagnosis of Dysthymic disorder, (2) those who met criteria for MDE 
after meeting criteria for dysthymic disorder, and (3) those who had recurrent MDE 
throughout two-years with incomplete resolution between episodes for two-years of time 
(Manber et al., 2008). Participants were prescribed nefazadone at 200 milligrams daily 
for week one and were titrated upward by 100 milligrams each week until participants 
were taking at least 300 milligrams or a maximum of 600 milligrams of nefazadone daily. 
Participants placed into the psychotherapy group received a combination of behavioral, 
cognitive, psychodynamic, and interpersonal psychotherapies twice a week; week one 
through week four; then one time each week; weeks 5 through weeks 12. Participants 
who still needed therapy twice weekly throughout the duration of the study continued to 
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receive therapy biweekly (Manber et al., 2008). Results from the study showed that 
28.9% of the participants who received a combination of pharmacotherapy and 
psychotherapy went into remission, in comparison to 14.1% of those who received 
psychotherapy or medication monitoring alone (Manber et al., 2008). The available data 
did not lend to the understanding of why the occurrence and the recurrence rates for 
MDD continued to rise but indicated that further studies are necessary.   
A Brief Review of Cognitive Behavior Therapy 
 Cognitive behavior therapy (CBT) combined behavioral approaches while having 
recognized how cognition affected the behavior of the individual (Corey, 2009). There 
were various theories of CBT, but all of the cognitive behavioral methods of 
psychotherapy were geared toward short-term treatment (Corey, 2009). In addition, all 
forms for CBT maintained the importance of having a team approach between the client 
and the therapist, and that the client was an active participant in his or her own psycho-
educational learning process (Corey, 2009). Furthermore, all forms of CBT maintained 
the premise that changing cognitions would result in a change in behavior, and that short-
term treatment which focused on targeting problems was most beneficial for the client 
(Corey, 2009). However, Beck’s cognitive therapy (CT) was specifically developed 
during his observations of clinically depressed patients (Corey, 2009).  
Beck’s Cognitive Model for the Treatment of Depression 
For the purpose of this study, the cognitive model for the treatment of depression 
as proposed by Beck, Rush, Shaw, and Emery (1979) was utilized to articulate the 
specific aspects of how individuals who suffered with depression became prone to 
negativity toward the self, experiences, and the future. The cognitive model also 
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proposed predisposing factors to depression, as early life experiences formed the 
foundation for developing negative schemas, which were then activated by similar 
experiences later on in life that made them prone to negativity (Beck et al., 1979). For the 
purpose of this study, the cognitive model for depression best explained why patients 
diagnosed with MDD became significantly less capable of forming positive responses on 
a standardized psychological assessment when compared to those with other forms of 
clinical mental illness, and when compared to those without clinical mental disorders. 
Beck’s cognitive model for the treatment of depression (1979) most precisely and 
concisely described what made the individual with depression prone to relapse and 
recurrence.  
Cognitive Theory of Depression 
According to Beck, Rush, Shaw, and Emery (1979) there were three aspects to the 
cognitive model of depression: the cognitive triad, schemas, and cognitive errors. The 
cognitive triad had three major cognitive patterns: The person’s negative view of the self, 
the tendency to interpret experiences negatively, and an overall depressive view of the 
future (Beck et al., 1979). Activation of these negative cognitive patterns led the person 
to behave as if his or her negative thoughts were actual reality. For example, if a person 
believed he would never do anything right, he tended to view all of his attempts as 
failures, even though this was not actually true. Thus, the person believed his entire 
future was doomed to failure and acted as if it were already the reality. As a result, this 
person likely experienced additional symptoms of depression, simply from being 
convinced that his thoughts were equivalent to what was real, and attracted negative 
consequences by his behavior (Beck et al., 1979).  
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The cognitive model maintained that avolition, escapism, and the tendency to 
avoid life situations were motivational symptoms and were a result of the negative 
cognitions (Beck, Rush, Shaw, & Emery, 1979). Suicidal thoughts were viewed as one of 
the extreme examples of escapism for the patient (Beck et al.). The cognitive model also 
explained that the negative cognitions led to physical symptoms of depression and an 
overall tendency to become slow, lethargic, and prone to feeling physically compromised 
(Beck et al., 1979).  
 The structural organization of depression or schemas explained why people 
maintained painful or self-defeating attitudes about themselves or aspects of their life, 
despite objective evidence to the contrary (Beck, Rush, Shaw, & Emery, 1979). The 
cognitive model (1979) proposed that when one was confronted with a life situation, a 
schema related to that particular situation became activated within the person. The 
schema was the basis of how data formed into cognitions and constituted the basis for 
screening out, discriminating, and recognizing the information in the situation that was 
confronting the patient (Beck et al., 1979). Types of schemas would determine how the 
individual structured different experiences and how the person used schemas to relate to 
life situations when depressed.  
 Errors in cognition were the third component in the cognitive model of 
depression. Incorrect thinking resulted in the person consistently having maintained his 
thoughts were true, despite consistent evidence to the contrary (Beck et al., 1979). 
Therefore, a person with errors in cognition could have had a team of practitioners who 
articulated facts and showed data that contradicted the person’s beliefs, and the patient 
still maintained that his thoughts were true.  
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Observing Beck’s Cognitive Theory for the Purposes of This Study 
 It was important to acknowledge that the current professional literature showed 
researchers tended to incorporate variations in cognitive behavioral therapy as they 
studied MDD (Corey, 2009). However, this study proposed to explore MDD from the 
cognitive theory of depression proposed by Beck, Rush, Shaw, and Emery (1979). It was 
my opinion that having isolated Beck’s important theoretical perspective of depression 
will have produced a distinct perspective in the study the positive response rates of 
persons with MDD. It was also important to note that there were practitioners who still 
utilized and investigated the CT in current day research (Dozois, Bieling, Patelis-Siotis, 
Hoar, Chudzik, McCabe, & Westra, 2009). Therefore, for the purposes of this study, CT 
was operationally defined and followed by the original model of treatment for depression 
(Beck et al.).   
Operational Terms 
 The cognitive model of depression proposed by Beck, Rush, Shaw, and Emery 
(1979) described six operational terms that provided psychologists with a framework to 
address the skills and language needed to work with the MDD population. They included: 
1.  Arbitrary inference:  The tendency for a person to have formed conclusions 
despite evidence that these conclusions were incorrect. 
2.  Selective abstraction: Occured when a person took a detail out of context and 
formed their belief of an entire experience on that perception, while being 
unable to have seen the most important parts of the experience.  
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3. Overgeneralization: Referred to the tendency for a person to take one incident 
and to have formed an overall conclusion toward related and unrelated 
circumstances. 
4. Magnification and minimization: Occurred when the person made errors in 
assessing an event to the extent where such errors were considered to be 
unrealistic. 
5. Personalization: Referred to the tendency for the patient to make external 
events about himself even when there was no basis for such perception. 
6. Dichotomous thinking: The tendency to have categorized experiences in one 
of two extremes, such as wonderful or horrible (Beck, 1976, p. 345).   
Cognitive Therapy for the Treatment of Depression 
 According to Beck, Rush, Shaw, and Emery (1979) cognitive therapy (CT) was 
founded by the theoretical notion that the behavior of an individual was primarily shaped 
by his cognitions, which were formed from schemas developed during previous 
experiences. The goal of cognitive therapy was to help the client work on changing 
distorted beliefs about the self, life situations, and the future, by having identified the 
schemas that underlie the distorted beliefs (Beck et al., 1979). The client eventually 
learned to correct his own thinking by evaluating his thoughts and correcting them to 
function in a more adaptive manner. The patient learned how to monitor negative 
thoughts. The patient learned how to see the connection between thoughts, emotions, and 
behaviors. The patient learned how to determine whether there was actual evidence to 
either support or dismiss the negative thought, and then would form a thought, which was 
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based on reality. This would help the patient to alter the negative schemas that underlied 
the automatic, negative cognitions (Beck et al., 1979).  
Cognitive Therapy With the Depressed Patient 
According to Beck, Rush, Shaw, and Emery (1979) the first interview with the 
patient usually occurred in the therapist’s office or over the telephone, and was conducted 
in a relaxed manner, while having maintained the professional boundaries and roles of the 
client-practitioner relationship. The practitioner might have utilized the initial interview 
to gain specific information about the client’s past mental health history, current life 
stressors, psychological challenges, attitude about psychotherapy, and motivation to 
pursue and engage in CT for treatment (Beck et al., 1979). Once the therapist gained this 
information, he would discuss the underlying principles for CT, the process of treatment, 
and provide the client with the booklet called Coping with Depression (Beck et al., 1979). 
The patient was then asked to identify any areas of the booklet that needed further 
explanation which could be considered as a first homework assignment. Sometimes in the 
first interview, the practitioner conducted a thorough mental status examination to 
determine diagnosis, or whether the patient evidenced suicidality or psychotic features, 
then labeled the chief complaint as a target symptom (Beck et al., 1979). The therapeutic 
goal of the initial interview was to provide the client with some relief for the severity of 
his symptoms, to have developed rapport, and to have established a sense of confidence 
for the therapeutic intervention of CT for future sessions (Beck et al., 1979). During the 
following sessions, the case history was obtained to include personal data, and prior 
assessments; then plans were developed for each CT session and homework was assigned 
for the client (Beck, Rush, Shaw, & Emery, 1979). The homework assignments were 
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specific and instructed the patient to keep a record of how he was actually functioning; to 
have identified problems he viewed as contributing factors to the depression; to have 
developed or continued a schedule which included pleasurable activities; and to have 
made notes of periods of sadness, anxiety, apathy or depressed feelings so that the 
underlying cognitions or schemas were identified and worked through during CT sessions 
(Beck et al., 1979). There were approximately 20 CT sessions with the patient and 
psychological assessments were completed throughout the duration of treatment in order 
to have determined how he was functioning. Once the 20th session was completed, the 
CT practitioner usually had the patient return for a one-month, two-month, and 6-month 
follow up session to assess his level of functioning (Beck et al., 1979).  
Evaluations of the structure of the self-schema in the original CT were 
investigated by Dozois and Dobson (2001) when they had participants complete a 
computerized task in which they rated self-referential adjectives on the basis of their own 
self-description. These participants were retested 6 months later, and data indicated 
negative cognitive organization still remained stable across time in individuals who did 
not meet criteria for MDD (Dozois & Dobson). Further studies showed that negative 
content remained well organized in both individuals who did meet criteria for MDD, and 
for those who did not fully meet criteria for MDD (Dozois & Frewen, 2006). These 
findings suggested that cognitive vulnerability could have been a factor consistent with 
Beck’s theories, and raised the question of whether CT could have changed cognitive 
organization (Dozois, Bieling, Patelis-Sioitis, Hoar, Chudzik, McCabe, & Westra, 2009). 
It was noted that three aspects of evidence proposed that CT did contribute to altering 
cogntive structures: (1) prophylactic effects of CT, (2) priming studies which indicated 
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cognitive differences between patients treated with CT versus those treated with 
pharmacotherapy, and (3) neruobiological data on the differenital neural responses to CT 
and antidepressant medication (Dozois et al.).   
Beck, Rush, Shaw, and Emery (1979) noted that the mental health practitioner 
Prerequisites to Conduct Cognitive Therapy for Depression 
had to meet certain qualifications to have correctly utilized cognitive therapy with 
patients. The practitioner had to have a thorough knowledge of depression as a clinical 
presentation of cognitive, motivational, behavioral, and physical symptoms, and had to  
recognize the strong tendency for recurrence and for suicidal thinking (Beck et al., 1979). 
According to Beck et al., mental health practitioners needed to demonstrate excellent 
skills in the following: psychotherapeutic intervention with a combination of technical 
skills, a sympathetic nature, comprehension of the cognitive model of depression, 
integration of the theoretical framework of cognitive therapy, participation in formal 
training conducting CT with clients under supervision, and continued training in CT with 
supervision after concluding formal CT training classes. In addition, the practitioner 
needed to be adept in evaluating for suicidal thoughts, and was required to have the 
ability to form immediate action to maintain safety for the patient and for others, and 
must have been able to form recommendations for treatment within a secure or 
hospitalized setting (Beck et al., 1979). 
The Combination of CT With Pharmacotherapy 
Beck, Rush, Shaw, and Emery (1979) documented that antidepressant medication 
could have a considerable benefit for those who suffered from severe depression; 
however, the degree of the therapeutic response, the overall appropriateness in having 
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used the medication, and the safety of the patient had to be considered when medication 
was prescribed for the treatment of depressive disorders. Medication monitoring might 
have contributed to the reduction of depressive symptoms, but medications alone were 
not associated with complete remission of symptoms on an ongoing, long-term basis 
(Beck et al., 1979).  
Despite CT and combination of CT with pharmacotherapy being reported as 
efficacious for the treatment of depression, the relapse and recurrence rates of MDD 
continued to propose there was a gap in the research literature (NIMH, 2011). A total of 
6.7% of the population in the United States was diagnosed with MDD with 30.4% of 
those cases labeled as severe (NIMH). This current study sought to explore what 
contributed to the ineffective treatments on a long-term basis with regard to the nature, 
duration, severity, and persistence of MDD. This study intended to add to the gap in the 
professional literature by having provided empirical data to highlight the possibility that 
indicators of cognitive impairments in those diagnosed with MDD, such as a decreased 
ability to form positive responses, needed to be recognized and addressed in more 
specific treatment methods.  
Cognitive Deficiencies Observed in Patients Diagnosed With MDD 
Riso et al. (2003) conducted an exploration of four cognitive approaches to 
chronic depression that included dysfunctional attitudes, early maladaptive schemas, 
attributional style, and the ruminative response style (Riso et al.). The four cognitive 
approaches were examined with the following groups; outpatient participants who met 
criteria for chronic dysthymic disorder, outpatient participants with nonchronic MDD, 
and participants without any history of psychiatric illness (Riso et al.). Results from this 
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study indicated that participants with MDD and participants with dysthymic disorder 
evidenced a significantly higher level of dysfunctional thinking, including early 
maladaptive schemas, dysfunctional attitudes, dysfunctional attributional styles, and 
ruminative response styles, when compared with the group of participants who were 
never psychiatrically ill (Riso et al., 2003). These results indicated the underlying 
cognitive mechanisms of psychopathology were present in both chronic dysthymic 
disorder and non-chronic MDD. Participants with chronic dysthymic depression showed 
more rigid, internalized, core beliefs such as an inability to set goals and exert self-
control which led to decreased autonomy, increased hypervigilence, and poor response to 
treatment (Riso et al., 2003). Petersen et al. (2007) also observed the pattern of more 
rigidly held beliefs and hypervigilence in people with recurrent and chronic depression. 
They noted the those with chronic depression made internal, global attributions to 
negative instances, and demonstrated external, unstable causation for positive 
experiences (Petersen et al., 2007).   
Riso et al. (2003) reported the findings in their study supported the additive model 
of depression, which said the cognitive factors underlying the predisposition to MDD and 
dysthymic disorder varied more in degree rather than in type. A limitation in their study 
was the lack of specificity with regard to cognitive factors that contributed to MDD. This 
limitation added credibility to the need for additional studies, as cognitive impairments 
appeared to be a contributing factor in resistance to treatment for those with MDD. My 
study intended to expand on this issue as an empirical contribution to the current 
professional literature.  
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 Riso et al. (2003) and Petersen et al. (2007) explored how particular cognitive 
symptoms predisposed individuals toward chronic depression. In contrast, Ruchshow et 
al. (2008) explored neurocognitive functioning to determine if there were cognitive 
deficits in patients diagnosed with MDD. Ruchshow et al. (2008) studied 
electroencephalogram (EEG) recordings of 14 right handed, German, participants 
diagnosed with MDD, and 14 right-handed, German, participants in a control group 
without MDD. The EEG readings were taken while these participants performed tasks 
with 144 experimental sentences and 48 filler sentences. The 144 experimental sentences 
were divided into three types; completely correct, syntactic mismatch, and semantic 
mismatch. Results indicated the participants diagnosed with MDD had longer reaction 
times when compared to the healthy participants in the control group. In addition, 
impairment in syntactic processing was noted in participants diagnosed with MDD when 
compared to the healthy control group of participants in the study (Ruchshow et al., 
2008). Future studies were needed to identify the nature and the severity of impairment in 
syntactic processing. The results of the study supported Beck’s (1979) cognitive model of 
depression as it showed that cognitive impairment is a significant component in 
individuals diagnosed with MDD. The results of the Ruchshow et al. (2008) study 
contradicted the notion proposed by Riso et al. (2003) that cognitive symptoms varied in 
degree rather than type for those with MDD.  
It was important for the community of mental health practitioners to recognize 
that varied degrees of cognitive dysfunction could become entirely different 
manifestations of mental illness when going from chronic dysfunction into clinical 
impairment. Current research revealed that gender was also a predisposing factor to 
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MDD (Harkness, Nazazin, Monroe, Slavich, Gotlib, & Bagby, 2010). My study proposed 
to be the first to use a standardized measurement to assess these gender factors. It is this 
identified gap in information that highlighted the need for additional studies to include 
empirical data that added to the current body of professional literature.  
Empirical Support for Gender Differences in MDD 
Harkness, Nazazin, Monroe, Slavich, Gotlib, and Bagby (2010) noted that one of 
the most pervasive findings was that a higher prevalence of MDD was noted in females 
versus males. The gender difference was noted to occur in early adolescence and reached 
a rate of two-to-one by mid-adolescence (Harkness et al.). This two-to-one rate was 
reported to occur until, at the very least, the end of middle life (Kessler, 2003). The 
NIMH (2011) reported that women are 70% more likely than men to experience 
depression during their lifetime, and that by the year 2008, a total of 8.1% of females 
were depressed in the United States when compared to a total of 4.6% of males. The 
American Psychiatric Association [APA] (2000) reported that women were of 
significantly greater risk for developing major depressive episodes at some point in their 
lives according to studies conducted in the United States and in Europe. Correlations 
occurred with the onset of puberty and several days before menses, and depressive 
episodes occurred twice as frequently in females than males [APA].  
Empirical Support for Differences in Stressful Life Events and MDD 
Psychologists researched the role of life stress and how it contributed to the 
development and the ongoing persistence of depression in individuals (Brown & 
Rossellini, 2011). One of the consistent findings was that stressful life events occur 
before major depressive episodes (Brown & Rossellini). This finding led many 
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researchers to focus on the causal effect on stress at the onset of depression in individuals 
vulnerable to the disorder (Brown & Rossellini). However, there were studies which 
investigated concurrent stressful life events during time periods of depression, and results 
indicated compromised outcome for depressed participants during follow-up periods of 
treatment (Brown & Rossellini). There was also evidence that ongoing, chronic, stressors 
may be the most predictive of depression severity, rather than acute, severe stressors 
(Brown & Rossellini). However, Brown and Rossellini (2011) also noted it was possible 
that different types or occurrences of stress led to different types of depression. For 
example: There were a number of studies that found acute stressors were associated with 
first episodes of depression rather than with recurrent depression (Brown & Rossellini). 
To the contrary, chronic, ongoing stress was generally more associated with chronic 
depression (Brown & Rossellini). Stroud, Davila, Hammen, and Vrshek-Schallhorn 
(2011) showed that two theoretical models were proposed to explain the connection 
between stress and depression in first onset and recurrent episodes of depression: (1) 
stress autonomy (SA) and (2) stress sensitization (SS). The model of SA suggested 
episodes of depression occurred autonomously of stress with repeated episodes, while the 
model of SS suggested that events of lower severity triggered depressive episodes with 
successive recurrences (Brown & Rossellini). Stroud et al. proposed that from the SS 
perspective, severe life events (SLEs) compared to lower life events (LLEs) were less 
likely to induce episodes of depression over the duration of time, because individuals 
became sensitized to stress. Stroud et al. further proposed that, due to this sensitivity to 
higher levels of stress, the individual was actually more likely to have been triggered by 
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lower level events of stress than acute, severe stressors, which was similar to what Brown 
and Rossellini (2011) found in ongoing stressors associated with chronic depression.  
Gender, Stressful Life Events, and MDD 
Harkness, Nazazin, Monroe, Slavich, Gotlib, and Bagby (2010) proposed the idea 
that men and women had differing predispositions to MDD when they experienced 
stressful live events (SLEs). They conducted a study to determine if SLEs correlated with 
an increased predisposition for MDD in women, with all participants specifically meeting 
the criteria for MDD without any other clinical mental disorder (Harkness et al., 2010). 
Participants who had developmental disorders, any other clinical mental disorder, 
personality disorder, or medical conditions were excluded from their study. All 
participants were administered the 21-item Beck Depression Inventory-II (BDI-II) and 
the Life Events and Difficulties Scale (LEDS-II) (Beck & Steer, 1993; Bifulco et 
al.,1989). A total of four studies were conducted to examine for gender difference in 
MDD (Harkness et al.). Three of the four studies were conducted with adult participants 
and included a total of 76 women between ages 18 to 65 living in the state of Oregon; a 
total of 100 adult men and women between ages 18-58 living in San Francisco, California 
and a total of 147 between ages 18 to 65 years recruited from the Greater Toronto region 
of Canada (Harkness et al.). Results from those three studies indicated women were 
significantly more likely to have an occurrence of MDD between ages 18-29, and they 
were also significantly more likely to report the occurrence of an SLE prior to the onset 
of MDD (Harkness et al.). Harkness et al. (2010) proposed the increased reports of SLEs 
and the symptoms of MDD by females were due to an increased predisposition to 
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negatively react to what they defined as SLEs; but that additional studies were needed to 
explore stressors in the male population diagnosed with MDD.  
Stroud, Davila, Hammen, and Vrshek-Schallhorn (2011) studied women’s 
predisposition to experience depression. The research examined severe life events (SLEs) 
and lower severity events (LLEs), in order to observe correlations within the onset of 
depression in 155 young adult female participants defined as middle-class, and 
approximately age 18-29 years of age (Stroud et al.). The study included cultural 
variation between Caucasian, Latina, Chicana, and Asian-American participants in their 
study conducted in Los Angeles, California, and the participants were followed for a 5-
year period of time (Stroud et al., 2011). The results identified whether life events were 
interpersonal, involved relationship loss, involved death, or a decreased tendency for 
SLEs with the recurrence of MDE. Relationship loss SLEs and LLEs were correlated 
with the first onset, and the prior onset of depressive disorder (Stroud et al., 2011). 
Despite the findings reported by Harkness et al. (2010) and Stroud et al. (2011) there was 
still a need for further investigation to more precisely determine why females were more 
prone to becoming depressed in the middle of stressful life events when compared to 
males. 
Research Methods Used in Previous Studies 
Mental health practitioners and researchers conducted hundreds of empirical 
studies focused primarily on psychotherapy and medication monitoring, to identify 
efficacious treatment of MDD. Some of the studies provided information on gender, as 
females appeared to be more prone to being diagnosed with MDD in early adulthood and 
upon reporting SLEs (Harkness et al., 2010). The study conducted by Stroud et al. (2011) 
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supported the previous findings and further identified that young females of various 
cultural backgrounds experienced relationship loss SLEs and LLEs that were correlated 
with the first onset and the prior onset of depressive disorder. However, the current 
research highlighted uncertainty as to why females were more prone to develop MDD 
than males, which supported the need for further studies.  
Riso et al. (2003) discussed the limitations of research and used the example that 
if females were shown to be more prone to MDD because of how they think, experience, 
and react to SLEs and LLEs prior to the onset of MDD, than it was important to study if 
males think, experience, and react differently than females with regard to SLEs and 
LLEs. It was important to gather empirical data to identify if there was a specific type of 
cognitive impairment that affected both males and females who were diagnosed with 
MDD, such as the inability to form positive responses on a standardized psychological 
assessment. This current study intended to explore if males and females diagnosed with 
MDD evidenced similar scores or significantly different scores, on the positive response 
scale of the CiOQ, which provided the empirical data necessary to highlight that there 
were cognitive impairments effecting males and females diagnosed with MDD. 
Summary 
A thorough review of the current professional literature identified a gap in the 
research which indicated if there was a specific cognitive impairment in those diagnosed 
with MDD that prevented them from forming positive responses and ultimately impeded 
their treatment. This study was a first step toward closing the gap in the professional 
literature acknowledging variables that contributed to the ongoing occurrence, relapse, 
and recurrence of MDD, due to an individual’s inability to form positive responses. This 
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study compared participants with MDD, to participants without any clinical mental 
disorder, in an attempt to learn if those with MDD had more significant cognitive barriers 
that interfered with their ability to benefit from the available treatment methods. This 
study was also a first step to observe whether females diagnosed with MDD were prone 
to score lower positive responses, when compared to males diagnosed with MDD. This 
study intended to show the possibility that those who suffered with MDD need more 
individual or specific interventions to learn how to circumvent their cognitive 
impairments, which contributed to their inability to form positive responses. This study 
had the potential to affect positive social change through an increased awareness that 
individuals diagnosed with MDD may be a globally underserved population, contributing 
to the rise in numbers who suffered relapse and recurrence.  
Chapter 3 included a discussion of the research methods proposed for the study, 
and included research design, setting and sample, instrumentation, data collection and 
data analysis procedures, and measures taken to protect the participants’ rights. 
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Chapter 3: Research Method 
The purpose of this study was to explore whether participants diagnosed with 
MDD demonstrated lower scores for positive responses on the positive response scale of 
the CiOQ when compared to participants without any clinical mental disorder. In 
addition, the study was designed to determine whether women diagnosed with MDD 
evidenced lower scores on the CiOQ when compared to men diagnosed with MDD. 
However, the study was limited in that it was not possible to assess the impact of cultural 
differences, due to the limitations of the demographics of the location of the study. 
Purpose of the Study 
 This chapter includes a description of the research design, the setting and sample, 
the instrumentation, data collection, and the procedures used for data analysis. This 
chapter also provides a description of the protection of participants’ rights. The first 
section of this chapter includes the research design and the justification for this approach. 
Next, the sampling procedures and sample sizes are described. In the third section, the 
instrumentation is defined, and details about the data collection tools and data related to 
each variable are provided. This is followed by a description of data collection 
procedures. The fifth section addresses the quantitative analysis method chosen for this 
study, the tested hypotheses, and the analytical tools that were used. The final section of 
this chapter includes a summary of the effort maintained to protect the rights of the 
participants.  
The purpose of this study was to explore whether participants diagnosed with 
MDD were more likely to evidence lower positive response rates on the CiOQ when 
compared to participants without any clinical mental disorder. In addition, I sought to 
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determine whether women diagnosed with MDD evidenced lower scores on the CiOQ 
when compared to men diagnosed with MDD. 
Research Design and Approach  
In this quantitative experiment, descriptive statistics were obtained. It was 
assumed that the values were normally distributed, and parametric statistical analysis was 
used. A between groups, 2x2 analysis of variance (ANOVA) included the two 
independent variables: diagnosis (MDD and no clinical mental disorder) and gender 
(male and female the CiOQ were significantly lower in participants diagnosed with MDD 
when compared to participants without any clinical mental disorder. This quantitative 
study also sought to determine if female participants diagnosed with MDD evidenced 
significantly lower scores on the positive response scale of the CiOQ when compared to 
male participants diagnosed with MDD.  This exploratory quantitative design was 
appropriate because the independent variables were expected to provide the data needed 
to answer the research questions (Gravetter & Wallnau, 2010). Because the CiOQ 
measure was used in the data collection, the goal was to determine if there were mean 
differences between the two groups, which made this a quantitative statistical approach 
(Gravetter & Wallnau, 2010). 
Setting and Sample 
Participants 
The research began at the counseling center in Michigan and concluded when the 
data collection was completed. The target population for this study was composed of 
participants who had been diagnosed with MDD and participants without any clinical 
mental health disorder. A sample size of 116 participants (30 male and 30 female 
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participants in the control group without MDD, and 30 female and 26 male participants in 
the group diagnosed with MDD) was collected to achieve a statistical power of 0.8 (a 
chance of a desired effect 80% of the time), given that the effect sizes were expected to 
be 1 or more (Gravetter & Wallnau, 2010). This was derived given the preferred 
standard, according to Joseph and Linley (2006), where the CiOQ was significantly 
different in people diagnosed with MDD. The purposive sampling method was chosen 
over random sampling to have selected participants for each group in the study, so that 
drawn conclusions on those populations would be based on their responses to the 
assessments in the study (Gravetter & Wallnau, 2010).   
Procedure 
First, I sought permission to perform the study from the director of the counseling 
center (see Appendix A). Then, I sought and obtained approval to conduct this study from 
the Walden IRB department and provided the approval number in the informed consent 
form (see Appendix B). Once approval to conduct the study was granted, I acquired the 
participants’ signatures on the informed consent form (see Appendix B). Once the 
signatures were obtained, all participants were administered the CiOQ (Appendix D). The 
instrument did not require any personal information, but each completed assessment was 
coded with an M for male or F for female, as well as 1 for MDD or 2 for no clinical 
mental disorder. Personal information for each participant was not included for the 
purposes of maintaining confidentiality, protecting the participants’ identities, and 
deidentifying the assessment instruments. The informed consent form, as determined by 
Walden University, apprised all participants of their right to withdraw their participation 
in the study at any time, for any reason without penalty.  
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Participants were first evaluated by the attending psychiatrist at the counseling 
center in Michigan and were expected to meet the following inclusion criteria: (a) they 
were between the ages of 18 and 49, (b) they were in overall good physical health, (c) 
they had been previously assessed at the counseling center, and (d) they were either male 
or female. Participants were excluded if the attending psychiatrist determined that they 
had a chronic or major medical illness or had a prior diagnosis of a developmental, 
personality, or comorbid clinical mental health disorder. The psychiatrist determined 
which patients met criteria to participate in one of the two groups being evaluated in this 
study: (a) those who met criteria for MDD according to the SCID-II and (b) those who 
did not meet any criteria for clinical mental disorders according to the SCID-II. 
Participants were men and women between the ages of 18 and 49 years who willingly 
provided informed consent as indicated by Walden University to participate in the study.  
The CiOQ was used to collect data from the participants. In research settings, 
psychological assessments are often used to increase the reliability of the information 
gathered for a study (Joseph, Williams, & Yule, 1993). Written permission to use the 
CiOQ was provided by the assessment’s publishers (Appendix C). The instrument is  
described in the following sections. The CiOQ was used to measure positive response 
scores on the positive response scales for all participants.  
CiOQ 
The CiOQ is a 26-item self-report assessment of positive and negative changes in 
responses, with a total of 11 items that measure for positive responses and 15 items that 
measure for negative responses (Joseph & Linley, 2006). The CiOQ was the first measure 
developed to assess positive and negative changes following adversity (Joseph, Williams, 
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& Yule, 1993). Joseph et al. reported satisfactory properties of internal consistency 
reliability for the positive and negative change scales on the CiOQ (.83 and .90, 
respectively), and the positive and negative change scales are uncorrelated (r = .12) 
(Joseph et al., 1993). For the purposes of this study, the 11 items of the positive response 
scale were used to measure the scores of positive responses for all participants in this 
study. The 11 items on the positive scale of the CiOQ were summed to give a total raw 
score of 11 to 66 (Joseph & Linley, 2006). Each item on the positive response scale was 
rated by a response on a Likert scale that ranged from 1 through 6, with 1 indicating 
strongly disagree and 6 indicating strongly agree (Joseph & Linley, 2006). A response of 
4 indicated agree a little on the Likert scale and was necessary for the response to be 
considered positive (Joseph & Linley, 2006). For example, an item on the positive 
response scale might have asked the participant if it was possible for him or her to 
perceive his or her future in a positive way. This study only explored the positive 
responses of participants; therefore, the negative scale of the CiOQ was not used.  
Joseph et al. (2005) examined the internal consistency, reliability, and convergent 
and discriminant validity of the CiOQ, and results indicated that the internal consistency 
and reliability of the positive and negative change scales were satisfactory. Linley et al. 
(2003) reported internal consistency reliabilities of .89 for the positive change scale and 
.84 for the negative change scale after examining 108 British participants who were 
exposed to the terrorist attacks of September 11, 2001. Joseph et al. (2005) examined for 
convergent and discriminant validity by comparing the CiOQ to four other scales 
developed to assess for positive changes. Results of partial correlations revealed that 
scores on the CiOQ were not correlated with scores on the Perceived Benefit Scales 
48 
 
(PBS); (r =.18) or the Post Traumatic Growth Inventory (PTGI); (r =.17), which 
evidenced the internal consistency reliability and convergent discriminant validity of the 
CiOQ (Joseph et al., 2003).  
Data Collection 
 Before data collection began, an approved application was obtained from the 
Institutional Review Board at Walden University (IRB #12-18-12-0039716) which 
granted permission to access participants and collect data from the counseling center. 
Then, the director of the counseling center was contacted by phone and informed the 
study could commence.  
 The data were reported in aggregate form and used for research purposes only. All 
data obtained throughout the study were immediately placed into an envelope, and kept in 
a secured cabinet within the counseling center, under lock and key. Only the researcher 
and the Director of the counseling center had access to the key. When data collection was 
complete, the researcher conducted a statistical analysis. 
Restatement of the Research Questions and Hypotheses 
The following research questions were formulated to guide the study: 
Research Question #1: Will there be a difference in positive responses when those 
diagnosed with MDD are compared to participants without a diagnosis of MDD? 
Ho1 :Participants diagnosed with MDD will not report significantly lower scores 
of positive responses as measured by the CiOQ when compared to participants without a 
diagnosis of MDD. 
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Ha1 :Participants diagnosed with MDD will report significantly lower scores of 
positive responses as measured by the CiOQ when compared to participants without a 
diagnosis of MDD. 
Research Question #2: Will there be a gender difference in the number of positive 
responses in those who are diagnosed with MDD? 
Ho2 :Female participants diagnosed with MDD will not report significantly lower 
scores of positive responses as measured by the CiOQ when compared with males 
diagnosed with MDD. 
Ha2 :Female participants diagnosed with MDD will report significantly lower 
scores of positive responses as measured by the CiOQ when compared with males 
diagnosed with MDD. 
Data Analysis 
A descriptive analysis was chosen to examine the hypothesis, and to credibly and 
effectively answer the research questions. A 2x2 ANOVA was used for this study, where 
each participant in the two independent variables fell into one of the two categories, 
(MDD diagnosis and no diagnosis of MDD) and one of the two categories for gender 
(male, female). The dependent variable was the scores on the positive response scale of 
the CiOQ. The 2x2 ANOVA was the appropriate statistical analysis to examine the data. 
The purpose was to examine if there was a significant difference between whether 
participants diagnosed with MDD would evidence statistically lower scores of positive 
response rates on the CiOQ when compared to participants without a diagnosis of MDD. 
In addition, the purpose of this study was to examine if there was a significant difference 
between female participants diagnosed with MDD, and statistically lower scores on the 
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CiOQ, when compared to males diagnosed with MDD.  If the overall 2x2 ANOVA was 
significant then a post hoc test such as the Tukey HSD was used. The participants were 
determined by their completion of all of the materials and by meeting the criteria for 
inclusion in the study.  
 The SPSS Statistical package for Social Science (version 20.0.0) was used to 
analyze the frequencies of the scores in the data collected with the instruments described. 
The descriptive statistics included the means and standard deviations for all quantitative 
data. Bar graphs were used to compare scores on the CiOQ and describe significant mean 
differences among three or more categorical variables. In this study, a series of bar graphs 
were presented to summarize and display differences in scores on the CiOQ between 
female participants and male participants diagnosed with MDD (Gravetter & Wallnau, 
2010).  
Protection of Participants’ Rights 
All information obtained throughout this study was kept confidential by the 
researcher under lock and key. The study consisted of participants who were previously 
assessed and diagnosed at the counseling center. All sensitive data obtained throughout 
the study was under the control and protection of the researcher at all times. All research 
requiring computer software was transferred to an external flash drive. All data obtained 
throughout the study was coded in a format, with an M for male, F for female, 1 for 
MDD, and 2 for no diagnosis of MDD. Personal information for each participant was 
removed for the purpose of maintaining confidentiality, protect the participants’ 
identities, and the assessment instruments was de-identified, immediately placed into an 
envelope, and kept in a secured cabinet within the counseling center, under lock and key. 
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Only the researcher and the Director of the counseling center had access to the key. When 
data collection was complete, the researcher conducted a statistical analysis. The 
researcher was aware of the importance of protecting the confidentiality for each 
participant and made every effort to satisfy this condition. This researcher was bound by 
professional and ethical standards to maintain strict confidentiality. An agreement with 
the counseling center was in place and included consequences if the researcher was to 
breach these standards in accordance with the professional code of ethics (see Appendix 
A). Collected data, stripped of any identifying pieces of information, was made available 
to qualifying professionals upon request to the researcher. When all of the data was 
collected, it was analyzed and kept in a secured cabinet under lock and key for a 
minimum of 5 years. If any participant was determined to be suicidal, he or she was 
immediately referred to the Director of the facility. 
Summary 
This chapter described the research design, setting and sample, instrumentation, 
data collection and data analysis procedures, and the participant’s rights and protection of 
the data. The CiOQ was used to measure the number of positive responses in each of the 
three groups (variables) being compared in this study. A 2x2 ANOVA was used for this 
study, where each participant fell into one of the two categories of independent variables: 
1) MDD and no diagnosis; 2) gender (male, female). The dependent variable was the 
scores on the positive response scale of the CiOQ. A 2x2 ANOVA, the method of choice 
for this study was explained and the results of this study were reported in a future chapter 
in narrative and tabular format. Conclusions were drawn based on the findings in this 
study. Recommendations were offered for practical application and future research.  
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Chapter 4 presents the research findings of the study. This chapter also includes 
the methods of the study, a description of the sample, the results of each research 
variable, an overview of the procedures, and a summary of the results. The results of the 
study were indicated in tabular and textual form. Chapter 5 provided a brief overview of 
the study, an interpretation of the study’s results, implications for social change, and 
recommendations for action and further research.  
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Chapter 4: Results  
This chapter describes the time frame for data collection as well as the actual 
recruitment and response rates. Chapter 4 also presents any departures in data collection 
from the plan presented in Chapter 3. This chapter reports baseline descriptive and 
demographic characteristics of the sample. Additionally, Chapter 4 describes how 
representative the sample was of the population of interest or how proportional it was to 
the larger population (external validity). The results are reported with appropriate tables 
and figures for illustration.  
The purpose of this quantitative exploratory study was to determine if individuals 
who were diagnosed with MDD evidenced significantly lower scores on the positive 
response scale of the CiOQ when compared to others who were not diagnosed with 
MDD, and to determine if women who were diagnosed with MDD scored lower on the 
positive response scale of the CiOQ when compared with men who were diagnosed with 
MDD. 
Assumptions and Analysis 
To address Hypotheses 1 and 2, a two-way analysis of variance (ANOVA) was 
conducted on CiOQ scores by gender (male vs. female) and group (control vs. treatment). 
Significant interaction effects between gender and group were analyzed with independent 
sample t tests to determine where significant differences were among gender level and 
group level. The main effect of gender on CiOQ scores was analyzed by an independent t 
test to determine where differences were among participants in the treatment group and 
the control group. Prior to the analysis, the assumptions—normality and equality of 
variance—were assessed.  Normality on CiOQ scores was assessed with a Kolmogorov-
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Smirnov (KS) test; the result was not significant, z(116) = 0.75, p = .636, indicating that 
the assumption was met.  Equality of variance was assessed with a Levene’s test; the 
result was not significant, F(3, 112) = 2.22, p = .090, indicating that the assumption was 
met. 
Research Question 1 
Would there be a difference in positive responses when those who were diagnosed 
with MDD were compared to participants without a diagnosis of MDD? 
H01: Participants who were diagnosed with MDD would not report significantly 
lower scores for positive responses as measured by the CiOQ when they were compared 
to participants without a diagnosis of MDD. 
Ha1: Participants who were diagnosed with MDD would report significantly 
lower scores for positive responses as measured by the CiOQ when they were compared 
to participants without a diagnosis of MDD. 
Research Question 2 
Would there be a gender difference in the number of positive responses in those 
who were diagnosed with MDD? 
H02: Female participants who were diagnosed with MDD would not report 
significantly lower scores of positive responses as measured by the CiOQ when they 
were compared with males who were diagnosed with MDD. 
Ha2: Female participants who were diagnosed with MDD would report 
significantly lower scores of positive responses as measured by the CiOQ when 
compared with males who were diagnosed with MDD. 
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Data Collection 
One hundred and sixteen participants took part in the survey over a 4-month 
period. Participants were assessed by the attending psychiatrist at the counseling center in 
Michigan and voluntarily completed the CiOQ for this study. Sixty (51.7%) participants 
were female, and 56 (48%) were male.  Similarly, 60 (51.7%) participants were in the 
group without MDD, and 56 (48%) were in the group diagnosed with MDD.  There were 
equal numbers of participants in the female group without MDD, the female group 
diagnosed with MDD, and the male group without MDD (30, 26%).  There were slightly 
fewer MDD males relative to the other three groups (26, 22%).  Frequencies and 
percentages for participants’ demographics are presented in Table 1.   
Table 1 
Frequencies and Percentages for Participants’ Demographics 
Demographic N % 
   
Group   
MDD  56 48 
Without MDD 60 52 
Gender   
Female 60 52 
Male 56 48 
Group and gender   
Females without MDD 30 26 
MDD females 30 26 
Males without MDD 30 26 
MDD males 26 22 
Note.  Percentages may not total 100 due to rounding error. 
 CiOQ scores ranged from 0 to 66, with mean (M) = 38.31 and standard deviation 
(SD) = 15.26.   
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Data Analysis 
A 2x2 ANOVA with statistical significance determined by p values < .05 was 
used for this study. Data were entered into SPSS version 20.0 for Windows.  Descriptive 
statistics were conducted to describe the sample demographics and the research variables 
used in the analysis.  Frequencies and percentages were calculated for gender and group.  
Means and standard deviations were calculated for CiOQ scores.  Data were screened for 
univariate outliers.  The presence of univariate outliers was tested by creating 
standardized residuals for the variables of interest and examining cases for values that fell 
above 3.29 and values that fell below -3.29 (Tabachnick & Fidell, 2012). 
Results 
The first null hypothesis (participants diagnosed with MDD would not report 
significantly lower scores for positive responses as measured by the CiOQ when 
compared to participants without MDD) was rejected. The main effect of group was 
statistically significant, F(1, 112) = 15.82, p < .001, partial η2 = .12, suggesting 
differences on CiOQ scores by group.  An independent samples t test was conducted, and 
the results showed that the control group had a significantly higher CiOQ mean score (M 
= 42.93) than the treatment group (M = 33.36).  The effect size (partial η2) of .12 
indicates a small difference between CiOQ scores for those participants in the treatment 
group and those in the control group. Thus, participants diagnosed with MDD scored 
significantly lower on the positive scale of the CiOQ than the control group. 
The second null hypothesis (female participants with MDD would not report 
significantly lower scores for positive responses as measured by the CiOQ when 
compared with males with MDD) was retained. The main effect of gender was 
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statistically significant, F(1, 112) = 14.39, p < .001, partial η2 = .11. This suggests that 
there were differences in CiOQ scores by gender.  An independent samples t test was 
conducted to examine where the significant differences resided.  The results of the t test 
showed that females had a significantly higher CiOQ mean score (M = 42.70) than males 
(M = 33.61).  The effect size (partial η2) of .11 indicates a small difference between 
men’s and women’s CiOQ scores. Thus, males diagnosed with MDD scored significantly 
lower on the positive scale of the CiOQ than the females diagnosed with MDD, and the 
second hypothesis was retained.   
The result of the interaction effect on CiOQ scores by gender and group was not 
statistically significant, F(1, 112) = 3.72, p = .056, partial η2 = .03, suggesting that CiOQ 
scores are not significantly different by the interaction of gender and group.  
The means and standard deviations on CiOQ scores by group and gender are 
presented in Table 2. The results of the two-way ANOVA are presented in Table 3. 
Figure 1 presents group-show scores by MDD versus non-MDD groups. Figure 2 
presents group-show scores by gender (male versus female). 
Table 2 
Means and Standard Deviations on CiOQ Scores by Group and Gender 
 MDD No MDD 
Gender M SD M SD 
     
Females 40.10 14.01 45.30 13.61 
Males 25.58 15.65 40.57 11.22 
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Table 3 
Two-Way ANOVA on CiOQ Scores by Gender and Group 
Source SS df MS F Sig. Partial 
η2 
       
Group 2943.96 1 2943.96 15.82 .001 .12 
Gender 2678.07 1 2678.07 14.37 .001 .11 
Group * Gender 692.17 1 692.17 3.72 .056 .03 
Error 20840.71 112 186.08 - - - 
 
 
 
Figure 1. Bar chart of CiOQ scores by group. 
 
59 
 
 
Figure 2. Bar chart of CiOQ scores by gender. 
Summary 
The scores of the CiOQ were significantly lower in participants who were 
diagnosed with MDD when compared to participants who were without any MDD 
diagnosis. In this quantitative study, I also sought to explore whether female participants 
who were diagnosed with MDD evidenced significantly lower scores on the positive 
response scale of the CiOQ when compared to male participants who were diagnosed 
with MDD. A total of 116 participants took part in the study. The participants included 
both men and women from two groups: individuals who had been diagnosed with MDD 
and a group without MDD. A two-way analysis of variance (ANOVA) was conducted on 
CiOQ scores by gender (male vs. female) and group (those without MDD vs. those 
diagnosed with MDD) to test both hypotheses. The results indicated that the first null 
hypothesis was rejected. Participants who had been diagnosed with MDD scored lower 
on the positive response scale of the CiOQ when compared with the group without MDD. 
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The second null hypothesis was retained, as it was found that men diagnosed with MDD 
scored lower than women diagnosed with MDD.  
Chapter 5 provides a brief summary of the study and explains why and how the 
study was undertaken and performed. Limitations of the study are discussed. Social 
change implications are also presented. Recommendations for future action and further 
research are offered. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
This chapter contains a concise overview of the purpose and nature of the study, 
why the study was conducted, and key findings from the study. An interpretation of the 
findings is provided, and comparisons between findings in this study and previous 
research are reviewed. A review of the limitations of the study is provided, and 
recommendations for further research are mentioned. Chapter 5 provides the implications 
for positive social change and ends with the conclusion of this exploratory study. 
Study Overview 
 The purpose of this study was to answer two research questions: (a) Were 
participants diagnosed with MDD cognitively unable to form positive responses on a 
positive response scale on a standardized psychological assessment when compared to a 
group of participants who were without MDD? (b) Were female participants diagnosed 
with MDD cognitively unable to form positive responses on a positive response scale on 
a standardized psychological assessment when compared to male participants who were 
diagnosed with MDD? My intention with this study was to take a first step in identifying 
whether mental health practitioners were overlooking a potentially important aspect of 
the ability of those with MDD to recover from their illness and be prevented from 
experiencing relapse: the cognitive ability to form positive responses in the midst of 
challenging life events. Prior to this study, there was no research that sought to 
investigate the cognitive capability of those diagnosed with MDD to form positive 
responses on standardized psychological assessments. There was a lack of empirical 
research despite the criteria of cognitive limitations for those diagnosed with MDD as 
indicated by the DSM-IV-TR (APA, 2000).  
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Summary of Results 
A total of 116 participants took part in the study. The number of participants 
included both males and females in two groups: those who were diagnosed with MDD 
and a group without MDD. A two-way analysis of variance (ANOVA) was conducted on 
CiOQ scores by gender (male vs. female) and group (those without MDD vs. those 
diagnosed with MDD) to test both hypotheses. The results indicated that the first null 
hypothesis was rejected. Participants diagnosed with MDD scored lower on the positive 
response scale of the CiOQ when compared with the group without MDD. The second 
null hypothesis was retained. Results showed that males diagnosed with MDD scored 
significantly lower on the positive response scale of the CiOQ when compared with 
females diagnosed with MDD. In fact, males diagnosed with MDD scored lower on the 
positive scale of the CiOQ than any other group in the study. 
Interpretation of Findings 
 This was the first study to investigate positive response rates in individuals 
diagnosed with MDD when compared with a group without a diagnosis of MDD and 
positive response rates in women diagnosed with MDD compared with men diagnosed 
with MDD that attempted to connect with Beck’s (1979) cognitive model of depression. 
Throughout the duration of the study, I found that most of the findings supported Beck’s 
(1979) cognitive model of depression, as participants who were diagnosed with MDD 
scored lower on the positive response scales on the CiOQ than participants in the group 
without MDD. However, there were also findings that differed from one of the two 
hypotheses proposed in the study: Male participants diagnosed with MDD scored 
significantly lower on the positive response scales of the CiOQ when compared with 
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female participants diagnosed with MDD. In fact, the men who were diagnosed with 
MDD scored significantly lower on the positive response scale on the CiOQ than any 
other group that was examined in the study.  
Research Findings 
The finding that men diagnosed with MDD scored lower on the positive response 
scales on the CiOQ than women diagnosed with MDD was compelling. The hypothesis 
formed for this present study was based on prior research indicating that women were 
more likely than men to report symptoms of MDD (American Psychiatric Association, 
2000; Harkness et al., 2010; NIMH, 2011). However, what I noted was that none of the 
prior researchers ever sought to investigate how participants who were diagnosed with 
MDD would perform on cognitive tasks that demanded the ability to form positive 
responses on a standardized psychological assessment. My research showed that, contrary 
to prior research, when participants diagnosed with MDD were challenged with the task 
of forming positive responses in the midst of challenging life events, males who were 
diagnosed with MDD were significantly less able to form positive responses when 
compared with female participants who were diagnosed with MDD. This finding may 
have finally provided a window—a way to see how practitioners can identify when men 
are suffering symptoms of MDD even when they are not verbally reporting such 
symptoms by using the CiOQ as part of an intake assessment.  
In my professional experience with male and female patients referred for mental 
health treatment, I have often observed that women are more verbally open about their 
feelings, emotions, and sense of vulnerability, whereas men are often less verbal and 
more restricted in their expression of feelings, emotions, and sense of vulnerability. 
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Interestingly, the findings provided in my research suggest that, when presented with a 
questionnaire that asked men and women to nonverbally report their feelings and to write 
their responses on a standardized psychological assessment, the men who were diagnosed 
with MDD provided responses that clearly showed that they were not as able to form 
positive responses on a standardized psychological assessment when compared with 
women who were diagnosed with MDD.  
However, it is important to note that cultural differences may not have been 
accurately represented in this study, as this research was conducted in a small region of a 
state in the midwestern part of the United States. Due to the lack of variation in the 
demographics of the geographic location, the demographic variables were limited to 
gender (Leu, Wang, & Koo, 2011). Thus, I would recommend that more studies be 
conducted to observe more culturally diverse populations.  
Theoretical Implications 
 Beck, Rush, Shaw, and Emery’s (1979) cognitive model of depression was 
supported by the findings of this study. Within the cognitive model of depression, there 
are three major cognitive patterns: the person’s negative view of the self, the tendency to 
interpret experiences negatively, and an overall depressive view of the future (Beck et al., 
1979). These cognitive patterns create greater likelihood that the individual will become 
increasingly negative and depressed (Beck et al., 1979). It was expected that participants 
who were diagnosed with MDD would score lower on the positive response scale of the 
CiOQ when compared with participants without MDD. The results from the study 
indicated that the participants who were diagnosed with MDD were less able to form 
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positive responses on a standardized psychological assessment when compared with 
participants without MDD.  
Limitations of the Theory 
 One of the limitations of Beck, Rush, Shaw, and Emery’s (1979) CT is that it does 
not propose the notion or potential importance of depressed individuals having the 
cognitive capacity to form positive responses in the midst of challenging life events. Beck 
et al. challenged patients to replace dysfunctional thoughts with rational thoughts, but 
they did not focus on developing positive responses in the midst of thoughts or situations 
that challenged clinically depressed patients.  
Implications for Social Change 
Societal Benefits 
 According to the current professional literature, the efforts of psychiatrists and 
psychologists to offer effective treatment methods for MDD have yielded limited success 
(NIMH, 2011). Research indicated that individuals diagnosed with MDD were provided 
with ineffective treatment plans for severe or long-term depression (Riso et al., 2003). As 
a result, those diagnosed with MDD were set up for failure more than for recovery when 
treating professionals encouraged them to attempt to perform therapeutic tasks in a 
similar manner to others who did not share the same incapacitating symptoms. This 
treatment pattern did not take into account that patients with MDD had a higher level of 
cognitive impairment that created a barrier to the performance of routine tasks.  
My study identified two important findings, bringing critical awareness to the 
mental health field and positive social change. The first important finding was that 
participants diagnosed with MDD scored lower on the positive response scale of the 
66 
 
CiOQ when compared with a group without MDD. This finding evidenced that those 
diagnosed with MDD needed more specified treatment plans that were geared to help 
them overcome their predisposition to negativity. Furthermore, psychologists, 
psychiatrists, and mental health practitioners could begin to develop specific forms of 
psychotherapy to help those diagnosed with MDD to develop insight into their 
predisposition to negativity. Mental health practitioners could further help those with 
MDD to replace negative cognitions with positive cognitions and to form long-term 
treatment plans for them to strengthen their ability to form positive responses in the midst 
of challenging life events. 
The second important finding of this was contrary to what the second hypothesis 
proposed would be found in this study. Males who were diagnosed with MDD scored 
significantly lower on the positive response scale of the CiOQ when compared with 
females who were diagnosed with MDD, and to both, males and females in the group 
who were without MDD. This study brought forth critical information about the severity 
of a type of cognitive impairment in those who were diagnosed with MDD, particularly 
in males diagnosed with the disorder. This is a finding not seen in any other research. 
This finding would contribute to positive social transformation within the field of 
psychology, as practitioners might have a way to reach males who are suffering with 
MDD even when they do not report symptoms.  
In the United States, men were often taught not to speak about emotion or any 
type of vulnerability. This might have prevented males from verbally reporting 
depression to their physicians and mental health practitioners. The use of the CiOQ as 
part of a brief intake assessment for male patients may provide crucial information about 
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depression when interviewing may not do so. This could bring about positive social 
transformation within the fields of psychology, psychiatry and the mental health field in 
general. The ability to administer the CiOQ to males upon intake assessment could create 
profound positive change for males who are suffering from MDD, their families, friends, 
colleagues, and for society at large. Practitioners could have a greater chance at detecting 
when males are severely depressed, and may further have the opportunity to teach 
depressed males how to replace negative cognitions with positive cognitions. 
Furthermore, males could have more of a chance to experience support from their mental 
health practitioners by experiencing the development of treatment plans that further assist 
them to follow through on replacing negative thoughts with positive thoughts. In 
addition, the treatment plans could teach patients with MDD to form proactive behaviors 
that support a healthier view and experience of life. In addition, these techniques and 
strategies could be taught to all individuals diagnosed with MDD. 
Research Limitations 
Despite the findings of this study and how they contribute to positive social 
transformation, this study was not without limitations. There was the possibility of 
participants answering questions in a way that would seem more appropriate or socially 
desirable to those viewing the answers (Paunonen & LeBel, 2012). There were 
limitations in the number of participants at the counseling center in Michigan. It would be 
beneficial to have more participants for studies like this one in the future. In addition, the 
counseling center was located in a small section of the Midwestern state of Michigan. 
There are various regional and cultural differences within the United States, let alone in 
other countries. Future researchers may want to broaden their horizons and conduct 
68 
 
further investigations of this type to see if the findings are similar, or if they differ in 
various parts of the United States and in other countries, as MDD is a disorder that affects 
people worldwide (NIMH, 2011). In addition, this study was limited to data obtained by a 
questionnaire that provided some insight into MDD, but now leaves practitioners with 
more questions. Additional research should investigate the implementation of 
psychotherapy that specifically teaches clients to form positive cognitions to replace 
negative cognitions over a period of time. Perhaps in the future, longitudinal studies can 
be conducted in order for mental health practitioners to see if such treatment plans are 
truly efficacious for those with MDD and other depressive disorders. 
Recommendations for Future Research 
This study, in and of itself, was a shift into positive social transformation, as it 
was the first of its kind. We, as mental health practitioners, need to further our 
investigation of the cognitive abilities of those diagnosed with MDD to form positive 
responses, rather than focusing entirely on the negativity of the disorder. As researchers, 
we need to search out of the box; beyond what is assumed and is already known. 
Researchers need to focus more specifically on how cognitive impairment in forming 
positive responses occurs in those diagnosed with MDD in different settings and 
environments; in different cultural backgrounds, and in different age groups. Mental 
health practitioners need to interview those who have recovered from MDD and note the 
differences and uniqueness that may help others with the disorder in the future. Research 
should focus on psychotherapy that is specifically developed to help those with MDD to 
form positive responses in the midst of challenging life events, such as Fredrickson’s 
(2001) broaden-and-build theory and the positivity ratio, (2009) which instructs 
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practitioners and depressed clients how to work with building positive responses in the 
midst of experiencing negative thoughts and challenging life events. Furthermore, 
research should continue to investigate the efficacy of integrating antidepressant 
pharmacotherapy with psychotherapy in order to increase the chances for long-term 
recovery and to prevent relapse and recurrence of MDD. 
Conclusion 
MDD is a disorder of global proportions. It affects individuals, families, friends, 
employers and employees, communities, organizations and society at large. Unlike other 
forms of depression, MDD contains a specific component, which has gone overlooked for 
far too long: Cognitive impairment; specifically, the inability for those with MDD to 
form positive responses in the midst of traumatic and stressful life events. This was 
clearly evidenced by the results obtained in this study, which utilized a standardized 
assessment that specifically measured for the precise ability to form positive responses. 
In a world that is becoming more and more challenging, we as mental health practitioners 
have a responsibility to meet the needs of our clients. It is imperative that practitioners 
continue to learn how to conduct thorough assessment and to follow through with the 
necessary forms of psychotherapy that will most thoroughly help clients recover, adapt, 
and face their challenges in life. Furthermore, it is our responsibility as psychologists to 
help patients to form the adaptive coping strategies that not only help them to survive, but 
to learn how to thrive. This should always be the goal of every mental health practitioner, 
and we are now one step closer to more effectively helping those with MDD. This study 
showed an aspect of the disorder that was being overlooked, and further showed us how 
to possibly detect when depressed males might not be verbally reporting the severity of 
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their depressive symptoms. We need to take this information and apply it every time we 
sense that someone sitting on the other side of our desk may be depressed.  
Depression is a lonely and potentially dangerous condition for those who suffer 
from it. As psychologists, we have the ability and the privilege to work with these 
patients; to help them heal and to discover a whole new way of looking at their world, if 
only we will take the time and make the opportunity to help those with MDD to shift 
their cognitions to a better, brighter place for themselves, their loved ones, and for 
society. Let us strive toward this contribution for those suffering with MDD, for their 
family and friends, and for society. 
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Appendix B: Informed Consent Form 
 
Informed Consent 
 
You are invited to participate in a dissertation research study investigating the impact of 
Major Depressive Disorder (MDD) and scores on positive scales of the Changes in 
Outlook Questionnaire, when compared to participants without any clinical mental 
disorder. 
 
Please read this form and ask any questions you may have before acting on this 
invitation to be in the study (contact information is provided below). 
This study is being conducted by Michelle Victoria, a doctoral candidate with the School 
of Psychology, Clinical Psychology licensure track program at Walden University, 
Minneapolis, MN. Walden University’s approval number for this study is IRB #12-18-
12-0039716, and it expires on December 17, 2013. 
 
Background Information (Importance and Reason for this Study): 
The results of this study will help mental health professionals in assessing and treating 
persons with Major Depressive Disorder. 
 
Purpose of the Study: 
The purpose of this study is to determine the relationship between Major Depressive 
Disorder and scores on the positive response scale of the Changes in Outlook 
Questionnaire, when compared to participants who are not diagnosed with any clinical 
mental disorder. 
 
Procedure: 
Dr. Yeragani will prescreen the individuals to identify those with a diagnosis of MDD or 
those with no clinical diagnosis. If the individual is willing to participate; the researcher 
will present the Informed Consent Form, obtain the signature of the potential participant, 
and once obtained, the researcher will administer the CIOQ psychological assessment 
questionnaire. Each assessment will receive a code indicating a letter M or F to identify 
gender of the participant, and a number to indicate the MDD diagnosis or to indicate no 
diagnosis. No other identifying data will be entered anywhere on the rating scales. The 
CiOQ will not require a signature and will therefore be deidentified limiting any risk of 
violating the confidentiality of the participants.  
 
Confidentiality: 
Your participation is voluntary and all data will be kept confidential. Once you provide 
your signature to consent to participate in the study, no further personal identifying 
information will be collected. Your name is not required. All inventories will be kept 
confidential and results will be stored in a locked cabinet. No feedback will be given, and 
no follow-up action is required. The researcher will not use your information for any 
purposes outside of this research project. The researcher will not include your name or 
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anything else that could identify you in any reports of the study and therefore the 
collected data will be deidentified. 
Participant requirements for this study: 
1. Each participant must be an adult at least 18 years, and not older than 49 years of age. 
2. Each participant must have already been pre-screened by Dr. Yeragani. 
3. Each participant must be in overall good physical health. 
4. The study will include both male and female participants. 
5. Each participant must be fluent in English. 
6. Each participant must provide consent to participate in the study. 
7. If you consent to participate in the study, you will be required to complete the Changes 
in Outlook Questionnaire which will take about 15 minutes. 
 
Participant’s rights 
Participation in this study is strictly voluntary. All participants have the right to withdraw 
their participation in the study at any time.  
 
Risks and Benefits of Being in the Study: 
There are minimal risks associated with participating in this study. This study does 
require self-assessment that may elicit negative self-emotions. Some questions might 
address sensitive topics and cause mild anxiety. You may stop participating in the study 
at any time by choosing not to answer any more questions and exiting from the study. 
You may skip any questions that you feel are too personal. If your participation results in 
emotional distress and requires support, the following emergency options are available in 
your community. If it is an emergency, please contact 911. Refusing or discontinuing 
participation involves no penalty. There will be no physical risks or compensation 
involved in participation. 
 
Incomplete surveys will not be used in the data analysis. However, participation in the 
survey may provide information that will be beneficial to professionals by helping to 
improve their understanding of Major Depressive Disorder and how it impacts adults, 
which could lead to improved services for individuals and their families. 
 
Compensation: 
There will be no compensation provided for your participation in this study. 
 
Contacts and Questions: 
If you have questions, you may contact the researcher by phone or e-mail. 
You may also contact the Faculty Advisor at  
Walden University Research Participant Advocate at (The Research Participant Advocate 
is a Walden University representative to whom you may direct any further questions you 
may have about your rights as a research participant.) If you want to talk privately about 
your rights as a participant, you may also call the study supervisor who can discuss this 
with you. Walden University's approval number for this study is IRB #12-18-12-0039716 
; it expires December 17, 2013. Please feel free to keep this form. 
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Statement of Consent: 
I have read the above information. I have asked questions and received answers. I 
consent to participate in the study. The completion of the inventories implies my consent. 
I have read and understand the risks, benefits, and confidentiality guidelines of this 
research study. I affirm that I am an adult, age 18 years or older. I affirm that I am in 
good overall health.  
 
I also consent to Dr. Vikram Yeragani’s participation in the statistical analysis process of 
the study and I am aware that the information he will have access to, has been 
deidentified and confidentiality will be maintained.  
 
 
Sincerely,  
Michelle Victoria, Ph.D. candidate, Walden University 
 
 
_ I wish to participate in this survey. 
 
Your Signature Provides Your Consent 
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